A detailed history of Principal Securities, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Principal Securities, Inc. holds 25,421 shares of AZN stock, worth $1.67 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
25,421
Previous 21,642 17.46%
Holding current value
$1.67 Million
Previous $1.69 Billion 17.34%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$76.67 - $87.62 $289,735 - $331,115
3,779 Added 17.46%
25,421 $1.98 Billion
Q2 2024

Jul 31, 2024

BUY
$66.81 - $80.83 $138,163 - $167,156
2,068 Added 10.57%
21,642 $1.69 Billion
Q1 2024

May 10, 2024

SELL
$61.03 - $69.57 $39,608 - $45,150
-649 Reduced 3.21%
19,574 $1.33 Billion
Q4 2023

Feb 07, 2024

BUY
$61.89 - $69.28 $1.25 Million - $1.4 Million
20,223 New
20,223 $1.36 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.